10x Genomics, Inc. (TXG) Stock

10x Genomics, Inc. is a prominent life science technology company that specializes in developing and marketing instruments, consumables, and software tailored for comprehensive biological system analysis across global markets including North America, Europe, Asia Pacific, and beyond. The company's product offerings encompass chromium and chromium connect instruments, microfluidic chips, slides, reagents, and various consumables essential for their proprietary single cell solutions.

At the core of 10x Genomics innovation are its chromium instruments, which enable cutting-edge applications such as single cell gene expression analysis for precise measurement of gene activity on a cell-by-cell basis. Additionally, the company's single cell immune profiling technology facilitates the detailed assessment of immune cell activity and their molecular targets. Their single cell Assay for Transposase Accessible Chromatin (ATAC) provides insights into epigenetic landscapes, revealing the physical organization of DNA. Moreover, the single cell multiome ATAC + gene expression platform allows simultaneous examination of genetic and epigenetic data in tens of thousands of cells within a single experiment.

Beyond single cell analysis, 10x Genomics offers the visium spatial gene expression solution, designed to map gene expression patterns spatially within a single tissue sample. This versatile technology extends its utility by enabling gene expression analysis combined with protein co-detection through immunofluorescence. Serving a diverse clientele including academic institutions, government bodies, biopharmaceutical firms, and biotechnology companies, 10x Genomics continues to redefine biological research capabilities with its state-of-the-art tools and comprehensive analytical solutions.